Tango Therapeutics said it completed its business combination with BCTG Acquisition, a SPAC sponsored by Boxer Capital.
Tango will begin trading on the Nasdaq tomorrow under TNGX. The company will have a total cash position of approximately $515 million after transactions costs, which includes approximately $342 million from BCTG’s trust account and the PIPE financing expected later today. BCTG’s shareholders approved the transaction Aug. 9.
BCTG stock redemptions totaled approximately $11 million, the companies said in a news release. Read more.
